TENS for Limb Function in Stroke: Design and Rationale for a Randomized Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2028

Conditions
Stroke
Interventions
DEVICE

Low-frequency(2HZ) TENS

Participants receive transcutaneous electrical nerve stimulation (TENS) at a frequency of 2Hz. The stimulation is delivered using surface electrodes placed on the affected upper limb. Each session lasts 30 minutes and is conducted three times per week for a total of 8 weeks. Intensity is gradually increased from 1 mA to 3 mA during each session.

DEVICE

High-frequency(100HZ) TENS

Participants receive TENS at a frequency of 100Hz using the same electrode placement and schedule as the 2Hz group. Sessions last 30 minutes, three times weekly for 8 weeks, with intensity increasing from 1 mA to 3 mA across the session. This group represents high-frequency stimulation.

DEVICE

Placebo TENS

Participants use a TENS device identical in appearance to the active treatment units. The power light is on, but no electrical stimulation is delivered due to internal circuit disconnection. Sessions follow the same schedule and duration as the active groups.

Trial Locations (1)

529000

Fuyong People's Hospital, Bao'an District, Shenzhen, Shenzhen

All Listed Sponsors
lead

CHENGNING Song

OTHER

NCT06997744 - TENS for Limb Function in Stroke: Design and Rationale for a Randomized Trial | Biotech Hunter | Biotech Hunter